Effects of chronic cirrhosis induced by intraperitoneal thioacetamide injection on the protein content and Michaelis-Menten kinetics of cytochrome P450 enzymes in the rat liver microsomes

被引:5
作者
Chandrashekar, Devaraj Venkatapura [1 ]
DuBois, Barent N. [1 ]
Rashid, Mamunur [1 ]
Mehvar, Reza [1 ,2 ]
机构
[1] Chapman Univ, Sch Pharm, Dept Biomed & Pharmaceut Sci, Irvine, CA USA
[2] Chapman Univ, Sch Pharm, Dept Biomed & Pharmaceut Sci, Harry & Diane Rinker Hlth Sci Campus, 9401 Jeronimo Rd, Irvine, CA 92618 USA
关键词
animal model; CYP2D; CYP3A; cytochrome P450; fibrosis; liver cirrhosis; Michaelis-Menten kinetics; thioacetamide; INDUCED HEPATIC-NECROSIS; S-OXIDE; METABOLISM; MODEL; DISEASE; BIOTRANSFORMATION; PHARMACOKINETICS; HEPATOTOXICITY; ADJUSTMENT; CLEARANCE;
D O I
10.1111/bcpt.13813
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Chronic intraperitoneal injection of thioacetamide (TAA) in rats has been used as an animal model of human cirrhosis to study the effects of the disease on drug metabolism. However, TAA inhibits P450 enzymes directly and independently of cirrhosis. We investigated the effects of chronic cirrhosis in rats, induced by 10 weeks of intraperitoneal TAA, on the P450 enzymes after a 10-day washout period to eliminate TAA. Liver histology and serum biomarkers of hepatic function confirmed cirrhosis in all animals. Microsomal total P450 content, P450 reductase activity and ethoxycoumarin O-deethylase activity, a general marker of P450 activity, were significantly reduced by 30%-50% in cirrhotic animals. Additionally, the protein content and Michaelis-Menten kinetics of the activities of CYP2D, CYP2E1 and CYP3A were investigated. Whereas cirrhosis reduced the microsomal protein contents of CYP2D and CYP3A by 70% and 30%, respectively, the protein contents of CYP2E1 were not affected. However, the activities of all the tested isoenzymes were substantially lower in the cirrhotic livers. It is concluded that the TAA model of cirrhosis that incorporates a 10-day washout period after intraperitoneal injection of the chemical to rats produces isoenzyme-selective reductions in the P450 proteins or activities, which are independent of the direct inhibitory effects of TAA.
引用
收藏
页码:197 / 210
页数:14
相关论文
共 49 条
[1]   CYP3A activity in severe liver cirrhosis correlates with Child-Pugh and model for end-stage liver disease (MELD) scores [J].
Albarmawi, Albader ;
Czock, David ;
Gauss, Annika ;
Ehehalt, Robert ;
Bermejo, Justo Lorenzo ;
Burhenne, Juergen ;
Ganten, Tom M. ;
Sauer, Peter ;
Haefeli, Walter E. .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 77 (01) :160-169
[2]   Differential alteration of cytochrome P450 isoenzymes in two experimental models of cirrhosis [J].
Bastien, MC ;
Leblond, F ;
Pichette, V ;
Villeneuve, JP .
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2000, 78 (11) :912-919
[3]   Drugs in liver disease [J].
Branch, RA .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1998, 64 (04) :462-465
[4]   Grading and staging the histopathological lesions of chronic hepatitis. The Knodell histology activity index and beyond [J].
Brunt, EM .
HEPATOLOGY, 2000, 31 (01) :241-246
[5]   Serial percutaneous liver biopsies in laboratory rats [J].
Corbin, IR ;
Minuk, GY .
DIGESTIVE DISEASES AND SCIENCES, 2003, 48 (10) :1939-1943
[6]   Rodent Models of Alcoholic Liver Disease: Role of Binge Ethanol Administration [J].
Dastidar, Shubha Ghosh ;
Warner, Jeffrey B. ;
Warner, Dennis R. ;
McClain, Craig J. ;
Kirpich, Irina A. .
BIOMOLECULES, 2018, 8 (01)
[7]   Liver Cirrhosis Affects the Pharmacokinetics of the Six Substrates of the Basel PhenotypingCocktail Differently [J].
Duthaler, Urs ;
Bachmann, Fabio ;
Suenderhauf, Claudia ;
Grandinetti, Tanja ;
Pfefferkorn, Florian ;
Haschke, Manuel ;
Hruz, Petr ;
Bouitbir, Jamal ;
Krahenbuhl, Stephan .
CLINICAL PHARMACOKINETICS, 2022, 61 (07) :1039-1055
[8]   Non-uniformity of Changes in Drug-Metabolizing Enzymes and Transporters in Liver Cirrhosis: Implications for Drug Dosage Adjustment [J].
El-Khateeb, Eman ;
Achour, Brahim ;
Al-Majdoub, Zubida M. ;
Barber, Jill ;
Rostami-Hodjegan, Amin .
MOLECULAR PHARMACEUTICS, 2021, 18 (09) :3563-3577
[9]   Scaling Factors for Clearance in Adult Liver Cirrhosis [J].
El-Khateeb, Eman ;
Achour, Brahim ;
Scotcher, Daniel ;
Al-Majdoub, Zubida M. ;
Athwal, Varinder ;
Barber, Jill ;
Rostami-Hodjegan, Amin .
DRUG METABOLISM AND DISPOSITION, 2020, 48 (12) :1271-1282
[10]   Liver cirrhosis: An overview of experimental models in rodents [J].
Faccioli, Lanuza A. P. ;
Dias, Marlon Lemos ;
Paranhos, Bruno Andrade ;
Goldenberg, Regina Coeli dos Santos .
LIFE SCIENCES, 2022, 301